Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04013789 · ClinicalTrials.gov registry record · NA
Comparison of Two Daily Disposable Lenses
A NA study of Myopia and Refractive Ametropia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT04013789: Completed NA study of Myopia and Refractive Ametropia, sponsored by Alcon Research.
NCT04013789 is a NA study of Myopia and Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 79 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04013789, a NA study of Myopia and Refractive Ametropia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to compare the clinical performance of the new DAILIES® AquaComfort PLUS® FreshTech (DACP FreshTech) contact lenses to an already marketed daily disposable contact lens, DAILIES® AquaComfort PLUS® (DACP).
Primary Outcome
VA was assessed at a distance of 4 meters using a letter chart and was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Conditions Studied
Interventions
- DEVICE DACP FreshTech contact lenses
- DEVICE DACP contact lenses
Study Locations (1)
Indiana
- Alcon Investigative Site - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2019-11-22 |
| Phase | NA |
What the finished NCT04013789 record still lists
NCT04013789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which DACP FreshTech contact lenses is the first listed.
NCT04013789 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04013789 about?
NCT04013789 is a clinical study titled "Comparison of Two Daily Disposable Lenses". The purpose of this study was to compare the clinical performance of the new DAILIES® AquaComfort PLUS® FreshTech (DACP FreshTech) contact lenses to an already marketed daily disposable contact lens, DAILIES® AquaComfort PLUS® (DACP).
What is the current status of trial NCT04013789?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2019-08-27. Estimated completion is 2019-11-22.
What conditions does trial NCT04013789 study?
This clinical trial studies the following conditions: Myopia, Refractive Ametropia.
What interventions are being tested in trial NCT04013789?
The interventions under investigation include: DACP FreshTech contact lenses (DEVICE), DACP contact lenses (DEVICE).
Who is sponsoring clinical trial NCT04013789?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04013789 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04013789's enrollment target sits among peer trials
79 47th of 90 higher than 44 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI